Drugs / Microginon®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00898560 | Sep → Nov 2008 | focal epilepsy | Bial - Portela C S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Microginon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00898560 ↗ |
| Route | Oral | “Single oral dose of Microginon® (30ug ethinyloestradiol and 150ug levonorgestrel)” NCT00898560 ↗ |